Resultats de la cerca - David T. Teachey

Refinar resultats
  1. 1
    Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)

    Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS) per David T. Teachey

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome

    New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome per David T. Teachey

    Publicat 2011
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Predicting relapse risk in childhood acute lymphoblastic leukaemia

    Predicting relapse risk in childhood acute lymphoblastic leukaemia per David T. Teachey, Stephen P. Hunger

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Diagnosis and Management of Autoimmune Cytopenias in Childhood

    Diagnosis and Management of Autoimmune Cytopenias in Childhood per David T. Teachey, Michele P. Lambert

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    T-cell acute lymphoblastic leukemia

    T-cell acute lymphoblastic leukemia per Elizabeth A. Raetz, David T. Teachey

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Autoimmune lymphoproliferative syndrome: more than a FAScinating disease

    Autoimmune lymphoproliferative syndrome: more than a FAScinating disease per Karen L. Bride, David T. Teachey

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Pré-impressão
    Afegir a favorits
    Guardat en:
  7. 7
    Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia

    Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia per David T. Teachey, Ching‐Hon Pui

    Publicat 2019
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children

    How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children per David T. Teachey, David O’Connor

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome

    Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome per Chelsea Kotch, David M. Barrett, David T. Teachey

    Publicat 2019
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy

    Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy per Andrew D. Hughes, David T. Teachey, Caroline Diorio

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Toxicity management for patients receiving novel T-cell engaging therapies

    Toxicity management for patients receiving novel T-cell engaging therapies per David M. Barrett, David T. Teachey, Stephan A. Grupp

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)

    Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS) per David T. Teachey, Alix E. Seif, Stephan A. Grupp

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies

    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies per David T. Teachey, Stephan A. Grupp, Valerie I. Brown

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies

    Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies per Sarah K. Tasian, David T. Teachey, Susan R. Rheingold

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    Cellular therapy: Immune‐related complications

    Cellular therapy: Immune‐related complications per Joseph H. Oved, David M. Barrett, David T. Teachey

    Publicat 2019
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia

    Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia per David T. Teachey, Stephen P. Hunger, Mignon L. Loh

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies

    Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies per David Barrett, Valerie I. Brown, Stephan A. Grupp, David T. Teachey

    Publicat 2012
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  18. 18
    CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

    CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia per Shannon L. Maude, David T. Teachey, David L. Porter, Stephan A. Grupp

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  19. 19
    Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies

    Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies per Shannon L. Maude, David M. Barrett, David T. Teachey, Stephan A. Grupp

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'

    Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL' per David T. Teachey, Michael R. Bishop, David G. Maloney, Stephan A. Grupp

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: